Ectosense

Ectosense specializes in home-use sleep apnoea recording systems. These devices are designed to monitor respiratory patterns during sleep, allowing consumers to track potential sleep apnoea events in an unsupervised setting. The focus is on enabling at-home assessment without the need for clinical oversight.

Ectosense is based in the United States. Since it manufactures Class II medical devices, its products fall under US regulatory frameworks, including compliance with FDA requirements. The company’s devices are listed in the FDA’s Unique Device Identifier (UDI) database, which helps ensure traceability and transparency in the regulatory system.

Ectosense’s devices are included in the FDA’s Unique Device Identifier (UDI) database. This registry helps track and identify medical devices authorised for use in the US, ensuring compliance with regulatory standards and facilitating market oversight.

Ectosense’s devices are classified as Class II medical devices in the US. This classification is based on their intended use—monitoring respiratory patterns for potential sleep apnoea—and the associated risk level. Class II devices typically require special controls beyond general controls to ensure safety and effectiveness.